Not applicableStudy completedNCT05684016
What this trial is testing
Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM
Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
George Washington University 75